Inter-department program of Pharmacology, Graduate School, Chulalongkorn University, Bangkok, Thailand.
Preclinical Toxicity and Efficacy Assessment of Medicines and Chemicals Research Cluster, Chulalongkorn University, Bangkok, Thailand.
Phytother Res. 2019 Oct;33(10):2531-2547. doi: 10.1002/ptr.6422. Epub 2019 Jul 10.
Cancer remains one of the leading causes of death worldwide, especially lung cancer. Chemotherapeutic drugs are commonly used for lung cancer treatment; nonetheless, undesirable side effects and drug resistance remain major challenges for therapeutic success. Therefore, harmless and effective treatments against lung cancer are urgently required. The use of natural phytochemical products, in single or combinatorial therapy, is an emerging strategy for prevention and cure of cancer because of the various remarkable anticancer properties of these compounds. Cell death, which primarily occurs via apoptosis and nonapoptotic mechanisms (necrosis, autophagy, and cellular senescence), is one of the antineoplastic effects of natural compounds. In this review, we highlight representative plant-derived compounds with cancer chemopreventive and sensitizing effects in combination with chemotherapeutic drugs with various cell death-inducing mechanisms. Relevant molecular mechanisms implicated in the pharmacological effects of these natural compounds are discussed. Overall, this review provides a reference and new perspective for application of phytochemical agents as potential anti-lung cancer drugs for further cancer drug research and development.
癌症仍然是全球主要死因之一,尤其是肺癌。化疗药物通常用于肺癌治疗;然而,不良副作用和耐药性仍然是治疗成功的主要挑战。因此,迫切需要针对肺癌的安全有效的治疗方法。由于这些化合物具有多种显著的抗癌特性,因此单一或联合治疗中使用天然植物化学产品是预防和治疗癌症的新兴策略。细胞死亡主要通过细胞凋亡和非细胞凋亡机制(坏死、自噬和细胞衰老)发生,是天然化合物的抗肿瘤作用之一。在这篇综述中,我们强调了具有抗癌预防和增敏作用的代表性植物源性化合物,这些化合物与具有多种诱导细胞死亡机制的化疗药物联合使用。讨论了这些天然化合物药理作用所涉及的相关分子机制。总的来说,这篇综述为植物化学制剂作为潜在的抗肺癌药物的应用提供了参考和新视角,以促进癌症药物的进一步研究和开发。